Cargando…
Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084080/ https://www.ncbi.nlm.nih.gov/pubmed/35837765 http://dx.doi.org/10.1111/all.15437 |
| _version_ | 1785021659960311808 |
|---|---|
| author | Alizadeh Aghdam, Mehran Hofman, Zonne L. M. Meertens, Michelle Lebens, Ans Hack, C. Erik Knulst, André C. Maas, Coen Röckmann, Heike |
| author_facet | Alizadeh Aghdam, Mehran Hofman, Zonne L. M. Meertens, Michelle Lebens, Ans Hack, C. Erik Knulst, André C. Maas, Coen Röckmann, Heike |
| author_sort | Alizadeh Aghdam, Mehran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10084080 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100840802023-04-11 Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema Alizadeh Aghdam, Mehran Hofman, Zonne L. M. Meertens, Michelle Lebens, Ans Hack, C. Erik Knulst, André C. Maas, Coen Röckmann, Heike Allergy Letters John Wiley and Sons Inc. 2022-07-22 2022-12 /pmc/articles/PMC10084080/ /pubmed/35837765 http://dx.doi.org/10.1111/all.15437 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters Alizadeh Aghdam, Mehran Hofman, Zonne L. M. Meertens, Michelle Lebens, Ans Hack, C. Erik Knulst, André C. Maas, Coen Röckmann, Heike Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title | Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title_full | Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title_fullStr | Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title_full_unstemmed | Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title_short | Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| title_sort | recombinant human c1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084080/ https://www.ncbi.nlm.nih.gov/pubmed/35837765 http://dx.doi.org/10.1111/all.15437 |
| work_keys_str_mv | AT alizadehaghdammehran recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT hofmanzonnelm recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT meertensmichelle recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT lebensans recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT hackcerik recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT knulstandrec recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT maascoen recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema AT rockmannheike recombinanthumanc1esteraseinhibitorasprophylactictreatmentinidiopathicnonhistaminergicangioedema |